bpc 157 and breast cancer Can a patient, post lumpectomy adjuvant radiotherapy, take BPC-157 (Body Protection Compound 157) for meniscal tears? Columbia Undergraduate Science Journal
Description
16 weeks 8-12 vials ~112 daily doses
The other three treatment groups were represented approximately equally in the largest cluster, with a maximum of one animal per treatment group outside the cluster
GI events (nausea, vomiting, diarrhea) were the dominant safety signal and occurred at rates higher than reported for Phase 2 retatrutide and higher than for comparable dual or mono-agonist trials
I have been working with Dr
